中心性浆液性脉络膜视网膜病变眼部特征的研究进展

doi:10.16352/j.issn.1001-6325.2024.01.0131

基础医学与临床 ›› 2024, Vol. 44 ›› Issue (1): 131-135.doi: 10.16352/j.issn.1001-6325.2024.01.0131

中心性浆液性脉络膜视网膜病变眼部特征的研究进展

肖星宇, 戴荣平^*

中国医学科学院北京协和医学院北京协和医院眼科眼底病重点实验室,北京 100730

收稿日期:2023-06-27 修回日期:2023-10-30 出版日期:2024-01-05 发布日期:2023-12-25
通讯作者: ^*:derricka@sina.com

Research advances on optical characteristics in central serous chorioretinopathy

XIAO Xingyu, DAI Rongping^*

Key Laboratory of Ocular Fundus Diseases, Department of Ophthalmology, Peking Union Medical College Hospital, CAMS & PUMC, Beijing 100730, China

Received:2023-06-27 Revised:2023-10-30 Online:2024-01-05 Published:2023-12-25
Contact: ^*:derricka@sina.com

摘要/Abstract

摘要： 中心性浆液性脉络膜视网膜病变(CSC)是一种以特发性浆液性视网膜脱离 (SRD)为特征的脉络膜视网膜疾病,伴有一处或多处视网膜色素上皮脱离(PED)或病变,具有特征性的眼球结构改变。CSC被归类为厚脉络膜相关疾病(PSD),近年来进一步发现主要为Haller层增厚。最近的研究重点关注了CSC患者的厚巩膜特征,阐述了其与脉络膜循环的密切关系,并提出CSC可能与葡萄膜渗漏综合征(UES)具有相似的发病机制。此外,CSC还具有短眼轴、远视性屈光不正、浅前房等特征,表明CSC不仅是眼球后极部的病变,而且累及全眼球。本文对CSC眼部特征的最新进展进行了综述,为进一步探究CSC发病机制提供新思路。

关键词: 中心性浆液性脉络膜视网膜病变, 巩膜厚度, 眼轴长度, 前房深度, 脉络膜厚度

Abstract: Central serous chorioretinopathy (CSC) is a chorioretinal disease that causes idiopathic serous retinal detachment (SRD), which is associated with one or more areas of pigment epithelial detachment (PED) or defect in the retinal pigment epithelium, also with characteristic ocular structural changes. CSC was classified as pachychoroid spectrum diseases (PSD); recent studies have found it mainly in Haller layer. Recent studies focused on the thick sclera in CSC patients, illustrated the close relation between which and choroidal circulation and put forward the probable pathogenesis similar to uveal effusion syndrome (UES). In addition, short axial length, hyperopia and shallow anterior chamber are also the characteristics in CSC patients, indicating that CSC is the disease not limiting to posterior oculus, but involving the whole oculus. This review summarizes the latest research advances on optical characteristics in CSC, providing the new ideas for further research on pathogenesis of CSC.

Key words: central serous chorioretinopathy, scleral thickness, axial length, anterior chamber depth, choroidal thickness

中图分类号:

R774.5

肖星宇, 戴荣平. 中心性浆液性脉络膜视网膜病变眼部特征的研究进展[J]. 基础医学与临床, 2024, 44(1): 131-135.

XIAO Xingyu, DAI Rongping. Research advances on optical characteristics in central serous chorioretinopathy[J]. Basic & Clinical Medicine, 2024, 44(1): 131-135.

参考文献 25

[1]	Kaye R, Chandra S, Sheth J, et al. Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities[J]. Prog Retin Eye Res, 2020, 79: 100865. doi:10.1016/j.preteyeres.2020.100865.
[2]	Imanaga N, Terao N, Nakamine S, et al. Scleral thickness in central serous chorioretinopathy[J]. Ophthalmol Retina, 2021, 5: 285-291.
[3]	Lee YJ, Lee YJ, Lee JY, et al. A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography[J]. Sci Rep, 2021, 11: 5872. doi:10.1038/s41598-021-85229-y.
[4]	Spaide RF, Fisher YL, Ngo WK, et al. Regional scleral thickness as a risk factor for central serous chorioretino-pathy[J]. Retina, 2022, 42: 1231-1237.
[5]	Mohapatra T, Trehan HS, Kurumkattil R, et al. Anterior scleral thickness in patients of central serous chorioretinopathy: a case-control study[J]. Oman J Ophthalmol, 2023, 16: 12-17.
[6]	Aichi T, Terao N, Imanaga N, et al. Scleral thickness in the fellow eyes of patients with unilateral central serous chorioretinopathy[J]. Retina, 2023, 43: 1573-1578.
[7]	Sawaguchi S, Terao N, Imanaga N, et al. Scleral thickness in steroid-induced central serous chorioretino-pathy[J]. Ophthalmol Sci, 2022, 2: 100124.
[8]	Terao N, Imanaga N, Wakugawa S, et al. Ciliochoroidal effusion in central serous chorioretinopathy[J]. Retina, 2022, 42: 730-737.
[9]	Imanaga N, Terao N, Sawaguchi S, et al. Clinical factors related to loculation of fluid in central serous chorioretinopathy[J]. Am J Ophthalmol, 2022, 235: 197-203.
[10]	Ishikura M, Muraoka Y, Nishigori N, et al. Widefield choroidal thickness of eyes with central serous chorioretinopathy examined by swept-source OCT[J]. Ophthalmol Retina, 2022, 6: 949-956.
[11]	Imanaga N, Terao N, Sonoda S, et al. Relationship between scleral thickness and choroidal structure in central serous chorioretinopathy[J]. Invest Ophthalmol Vis Sci, 2023, 64: 16. doi:10.1167/iovs.64.1.16.
[12]	Spaide RF, Gemmy CC, Matsumoto H, et al. Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders[J]. Prog Retin Eye Res, 2022, 86: 100973. doi:10.1016/j.preteyeres.2021.100973.
[13]	Terao N, Koizumi H, Kojima K, et al. Short axial length and hyperopic refractive error are risk factors of central serous chorioretinopathy[J]. Br J Ophthalmol, 2020, 104: 1260-1265.
[14]	Maltsev DS, Kulikov AN, Burnasheva MA, et al. Axial length as a basic anatomical predictor for morphological and clinical characteristics in acute central serous chorioretinopathy[J]. Eye (Lond), 2020, 34: 2063-2067.
[15]	Terao N, Imanaga N, Wakugawa S, et al. Short axial length is related to asymmetric vortex veins in central serous chorioretinopathy[J]. Ophthalmol Sci, 2021, 1: 100071. doi:10.1016/j.xops.2021.100071.
[16]	Ersoz MG, Arf S, Hocaoglu M, et al. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients[J]. Br J Ophthalmol, 2019, 103: 725-729.
[17]	Ravenstijn M, van Dijk E, Haarman A, et al. Myopic presentation of central serous chorioretinopathy[J]. Retina, 2021, 41: 2472-2478.
[18]	Lim LS, Lamoureux E, Saw SM, et al. Are myopic eyes less likely to have diabetic retinopathy?[J]. Ophthalmology, 2010, 117: 524-530.
[19]	Oh JH, Oh J, Togloom A, et al. Biometric characteristics of eyes with central serous chorioretinopathy[J]. Invest Ophthalmol Vis Sci, 2014, 55: 1502-1508.
[20]	Jirarattanasopa P, Ooto S, Tsujikawa A, et al. Assess-ment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy[J]. Ophthalmology, 2012, 119: 1666-1678.
[21]	Zeng Q, Yao Y, Tu S, et al. Quantitative analysis of choroidal vasculature in central serous chorioretinopathy using ultra-widefield swept-source optical coherence tomography angiography[J]. Sci Rep, 2022, 12: 18427. doi:10.1038/s41598-022-23389-1.
[22]	Nishihara S, Maruko I, Izumi T, et al. Peripheral choroidal thickness determined by wide-field optical coherence tomography in eyes with central serous chorioretinopathy[J]. Retina, 2022, 42: 1450-1454.
[23]	Izumi T, Maruko I, Kawano T, et al. Morphological differences of choroid in central serous chorioretinopathy determined by ultra-widefield optical coherence tomogra-phy[J]. Graefes Arch Clin Exp Ophthalmol, 2022, 260: 295-301.
[24]	Chung YR, Kim JW, Choi SY, et al. Subfoveal choroidal thickness and vascular diameter in active and resolved central serous chorioretinopathy[J]. Retina, 2018, 38: 102-107.
[25]	Luo Z, Xu Y, Xu K, et al. Choroidal vortex vein drainage system in central serous chorioretinopathy using ultra-widefield optical coherence tomography angiography[J]. Transl Vis Sci Technol, 2023, 12: 17. doi:10.1167/tvst.12.9.17.

中心性浆液性脉络膜视网膜病变眼部特征的研究进展

Research advances on optical characteristics in central serous chorioretinopathy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 25

相关文章 1

编辑推荐

Metrics

本文评价